CDLX - Cardlytics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
188,956
150,684
130,365
112,821
Cost of Revenue
118,125
96,003
80,259
72,412
Gross Profit
70,831
54,681
50,106
40,409
Operating Expenses
Research Development
12,507
16,210
12,150
13,902
Selling General and Administrative
83,721
76,106
52,027
52,616
Total Operating Expenses
100,220
95,598
67,205
70,737
Operating Income or Loss
-29,389
-40,917
-17,099
-30,328
Total Other Income/Expenses Net
-1,619
-8,861
5,697
-39,198
Income Before Tax
-32,137
-53,042
-19,641
-75,696
Income Tax Expense
-
0
0
0
Income from Continuing Operations
-32,137
-53,042
-19,641
-75,696
Net Income
-32,137
-53,042
-19,641
-75,696
Net Income available to common shareholders
-32,137
-53,199
-25,384
-76,678
EBITDA
-
-37,635
-14,071
-26,109